Clinical trial software for early-phase studies: EDC, eConsent, ePRO, and safety in one platform with 21 CFR Part 11–aligned controls and audit trails.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
On the Capture.Study platform, early-phase teams use the same modules and patterns that appear across the rest of the site: web-based study configuration, eConsent for informed consent, visit-based CRFs for safety and efficacy, and optional ePRO when patient-reported outcomes are in scope. Because these are configured rather than hard-coded, you can iterate quickly as protocols change, while still keeping audit trails and roles aligned with your governance model.
Because Capture lets you reuse core design elements, you can gradually standardize how early-phase studies are built and run. That means consistent safety panels, PK forms, and visit structures, plus predictable exports and documentation for validation. Over time, this reduces the effort required to launch each new early-phase protocol and makes it easier for cross-functional teams to work across a portfolio of trials.
Overview
Early-phase clinical trials (Phase 1, 1a, 1b, and early Phase 2) require a trial software stack that supports safety, PK, and early efficacy with rapid build and amendments. These programs are often exploratory, with adaptive elements and protocol refinements as data comes in, and they are usually run by lean teams who do not have the time or budget for multi‑month implementation projects. Your system must combine EDC, consent, ePRO when needed, and safety workflows with full auditability—without the cost and complexity of enterprise clinical trial software. It should help you standardize the way you capture data across early-phase programs (common safety panels, PK forms, and visit structures), while still letting you tailor each protocol’s details. Capture provides one platform with 21 CFR Part 11–aligned controls and HIPAA‑aligned security, so early-phase teams can go live quickly and adapt as protocols evolve, using a familiar, browser-based interface for study builders, site staff, and monitors.
Early-phase studies need agility: fast build, easy amendments, and one system for consent, CRFs, and safety. Enterprise trial software often adds implementation time, per‑seat costs, and change‑control overhead that doesn’t fit small cohorts and iterative protocols. At the same time, early-phase data still needs to meet regulatory and sponsor expectations for data integrity: clear audit trails, appropriate access controls, and exports that your analysis teams can trust. Capture is built for early-phase: one platform, one audit trail, and documentation to support sponsor validation when required, with a configuration-driven approach that lets you respond quickly when dose cohorts, schedules, or endpoints change.
FAQ
Explore the platform with a free sandbox. No sales call required.